Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001083814A3 Assay for nucleic acid analysis
10/02/2003WO2001083784A3 Method of site-specific insertion in zymomonas mobilis
10/02/2003US20030188347 Hybrid winter oilseed rape and methods for producing same
10/02/2003US20030188346 Methods for making plants tolerant to glyphosate and compositions thereof
10/02/2003US20030188345 Plasmid for efficient transfer of heterologous nucleotide sequences into monocotyledonous and dicotyledonous systems
10/02/2003US20030188344 Compositions and methods for agrobacterium transformation of plants
10/02/2003US20030188342 Gene related to regeneration ability of plants and uses thereof
10/02/2003US20030188341 Prevention of transgene escape in genetically modified perennials
10/02/2003US20030188339 Regulatory sequences for regulation of gene expression in plants and other organisms, and compositions, products and methods related thereto
10/02/2003US20030188338 Raspberry bushy dwarf virus (RBDV) protein/polypeptide for use in generating disease resistant plants
10/02/2003US20030188337 Transgenic plants
10/02/2003US20030188336 Trangenic plant coding insecticidal protein for use in biological pest control; disease resistant plants
10/02/2003US20030188335 Chimeric & endotoxin protein with extraordinarily high insecticidal activity
10/02/2003US20030188334 Magnesium chelatase
10/02/2003US20030188333 Using needle-like structures to facilitate transfer of DNA to plant cells; genetic engineering; transgenic plants
10/02/2003US20030188332 Amino acid transporters
10/02/2003US20030188331 Using zinc finger polypeptide to control gene expression in transgenic plants
10/02/2003US20030188330 Transgenic plant comprising recombinant polynucleotide sequences for propagating plants which are freeze, heat, drought, insect and disease resistant
10/02/2003US20030188329 Genetic construct comprising a conditionally lethal gene operably associated with promoter functional in plant cell, gene being used to select, identify or selectively kill a plant expressing said gene
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030188325 Genetically engineered rodent cells comprising mutated regulatory erythroid kinase (REDK) gene for treatment of blood disorders such as anemia; animal models
10/02/2003US20030188324 P300 transgenic animal
10/02/2003US20030187592 Association rule mining and visualization for disease related gene
10/02/2003US20030187591 Method of and apparatus for genomic analysis, and computer product
10/02/2003US20030187246 Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187243 Novel expression-regulating sequences and expression products in the field of filamentous fungi
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187199 Novel protein and gene
10/02/2003US20030187198 Polynucleotide sequences coding g-protein coupled receptor polypeptide for diagnosing and preventing neutropenia, inflammation and cell proliferative disorders; gene therapy
10/02/2003US20030187184 Viral peptide for use in diagnosis and treatment of liver disorders; genetic vaccines
10/02/2003US20030187056 Enzyme inhibitors; rolipram; antiinflammatory agents, bone disorders, respiratory system disorders, skin disorders
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186923 Ribozymes; cell growth and differentiation factors
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186921 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
10/02/2003US20030186920 Target genes and mRNAs encoding mammalian vascular endothelial growth factor(VEGF) receptors can be used to reduce VEGF-induced inflammation and angiogenesis; for treatmment of tumor growth and metastasis, ocular diseases, arthritis
10/02/2003US20030186916 Vector for transfection of eukaryotic cells
10/02/2003US20030186913 Introducing preparation comprising a pharmaceutically acceptable injectable carrier and naked polynucleotide operatively coding for the polypeptide into interstitial space of the heart
10/02/2003US20030186912 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/02/2003US20030186911 Inhibition of infectious agents by exogenous oligonucleotides
10/02/2003US20030186909 Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186903 Antisense modulation of MyD88 expression
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186885 Soluble polypeptides comprising extracellular domains or variable peptides of blood coagulation factors, used for immunotherapy or for prophylaxis of thrombosis and cardiovascular disorders
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186879 Nucleic acids that code for acylcoenzyme A; cholesterol acyltransferase (ACAT) required for viability protein (ARV1p), used to controlling lipid oil metabolism
10/02/2003US20030186878 Human longevity assurance protein, its coding sequence and their use
10/02/2003US20030186876 IL-6 antagonist peptides
10/02/2003US20030186871 Contacting a solution comprising an AKR1C polypeptide or fragment with agent, selecting an agent that modulates the expression or catalytic activity of AKR1C polypeptide or fragmet, thereby identifying an agent for therapy of diabetes
10/02/2003US20030186863 For production of peptidomimetic drugs that modulate a large class of proteins involved in signal transduction pathways and oncogenesis
10/02/2003US20030186851 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium
10/02/2003US20030186848 Recombinant iron uptake proteins
10/02/2003US20030186844 Gherlin analogs
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186443 Phytase active yeast
10/02/2003US20030186442 Efficient method of preventing growth of microbial genetic transformant after transformation
10/02/2003US20030186441 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
10/02/2003US20030186438 Premature osteoblast cell line derived from the peritoneum of bone for use as models for prevention and treatment of osteoporosis
10/02/2003US20030186435 Comprises antagonist that inhibits activity or expression oxidoreductase (FABH) for treating bacterial infection; bactericides
10/02/2003US20030186434 Method of forming vertebrate pancreas in vitro
10/02/2003US20030186431 Rabbit hemorrhagic disease vaccine and antigens
10/02/2003US20030186427 Apparatus for selectively converting photogenerated reagent precursors to photogenerated reagents associated with parallel synthesis of molecular sequence arrays on solid surfaces
10/02/2003US20030186425 Muscodor culture for use in generation of fungicidal, bactericidal, insecticidal and nematocidal compositions for biological pest control
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186423 Amidase from variovorax
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186420 Prolidase and its gene and method for producing prolidase
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186418 Novel variant EGIII-like cellulase compositions
10/02/2003US20030186417 Polypeptides and/or peptide sequences associated with pectin esterase (PME) for use as substituents of food stuffs; food processing
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186414 Nucleotide sequences coding chimeric enzymatic polypetide for biosynthesis of oligosaccharides
10/02/2003US20030186412 Polypeptides which asymmetrically reduce N-benzyl-3-pyrrolidinone to produce (S)-N-benzyl-3-pyrrolidinol with NADPH as coenzyme
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186402 Engineering fungi for the utilisation of l-arabinose
10/02/2003US20030186400 Method for producing optically active 2-hydroxycycloalkanecarboxylic acid ester
10/02/2003US20030186392 Biopolymer thickener
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186390 Detecting or determining transfer of nucleotide sequences via gene expression or reporter molecule expression analysis in transformed cells
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186378 Useful mutations of bacterial alkaline protease
10/02/2003US20030186376 Method for synthesizing proteins in a yeast of the genus Arxula and suitable promoters
10/02/2003US20030186374 Multimeric polypeptide plasmid for expression of complex heterologous proteins
10/02/2003US20030186371 Comprise sequences coding protein related to human leukocyte antigen-C (HLA-C) for diagnosis and treatment of skin disorders; animal models
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides